Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Elsevier Science full text link Elsevier Science Free PMC article
Full text links

Actions

Comment
.2021 Jul;9(7):682-683.
doi: 10.1016/S2213-2600(21)00171-5. Epub 2021 Apr 9.

Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19

Affiliations
Comment

Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19

Alvar Agusti et al. Lancet Respir Med.2021 Jul.

Erratum in

No abstract available

PubMed Disclaimer

Conflict of interest statement

AA and RF are the leading investigators of a multicentre, randomised clinical trial supported by AstraZeneca, which is currently exploring the effects of inhaled budesonide in hospitalised patients with COVID-19 pneumonia (NCT04355637).

Figures

None
See this image and copyright information in PMC

Comment on

References

    1. Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med. 2021;27:28–33. - PubMed
    1. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonar disease (GOLD) 2021.www.goldcopd.org
    1. Global strategy for asthma management and prevention (GINA) 2020 update. 2020.https://ginasthma.org/wp-content/uploads/2020/04/GINA-2020-full-report_-... - PubMed
    1. Halpin DMG, Faner R, Sibila O, Badia JR, Agusti A. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med. 2020;8:436–438. - PMC - PubMed
    1. Schultze A, Walker AJ, MacKenna B, et al. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform. Lancet Respir Med. 2020;8:1106–1120. - PMC - PubMed

Publication types

MeSH terms

Substances

Associated data

LinkOut - more resources

Full text links
Elsevier Science full text link Elsevier Science Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2025 Movatter.jp